In the past 50 years the survival rate for blood cancers has doubled, tripled or even quadrupled because of The Leukemia & Lymphoma Society's unwavering commitment to changing the face of cancer. LLS is the largest non-profit organization solely dedicated to treating blood cancers and has as its mission to make someday today for a world without blood cancers.
LLS has achieved its leadership position through a unique approach to research and fundraising. Its venture philanthropy model includes partnerships with pharmaceutical and biotechnology companies, academia, medical centers and the National Institutes of Health, to foster the process of drug discovery from basic research to translational and clinical research.
LLS has invested more than $875 million in developing better cancer treatments. In fact, LLS research has increased a child's survival rate for acute lymphoblastic leukemia (ALL) from 3% to 90% in the past 50+ years. In addition, many innovations such as multi-drug chemotherapy and stem cell transplantation started as blood cancer therapies. Nearly 50% of all cancer drugs newly approved by the U.S. Food & Drug Administration in the last 12 years were first approved for blood cancers.
To mark the extraordinary progress in this mission to cure blood cancers, LLS has unveiled its first-ever organization wide initiative, “Someday Is Today.” The initiative is rolling out in key markets around the country to have a critical impact on the future of blood cancers -- today. People talk about curing cancer someday, but for LLS, “someday” is not in the future, Someday is Today. Cures are happening today, and the reality is, lives are being saved right now.
As Chief Mission Officer, Dr. DeGennaro's responsibilities include oversight of all LLS mission functions: Public Policy, Patient Services and Research with the goal of effectively deploying resources in pursuit of the LLS mission...--- Read More
“We felt it was time to put a stake in the ground, and to shine the spotlight on the urgency and accomplishments we have made toward finding cures for blood cancers. ’Someday is Today’ is our platform to rally support for this...--- Read More
“Our objective is to build brand awareness so people have more knowledge of what we do and the impact of what we do. We’re telling our story in a humanistic and modern way that engages our 62 chapters and also provides a...--- Read More
“We felt it was time to put a stake in the ground, and to shine the spotlight on the urgency and accomplishments we have made toward finding cures for blood cancers. ’Someday is Today’ is our platform to rally support for this cause. People talk about curing cancer at some point in the future. But, for LLS, someday is today. Contributions made to this organization – through partners, volunteers and generous donors – are driving cures right now. The reality is, if you want to reduce the incidence of lung cancer, stop smoking. If you want to reduce the incidence of melanoma, use sun block. If you want to prevent the incidence of blood cancer, invest in a cure.”
“Our objective is to build brand awareness so people have more knowledge of what we do and the impact of what we do. We’re telling our story in a humanistic and modern way that engages our 62 chapters and also provides a marketing umbrella for the Leukemia & Lymphoma Society, because we want to make sure people have an emotional connection and are aware of our role in the battle against blood cancers.”
Whenever we talk abuot cancer, we always use the same word. Someday.
Someday there´ll be a cure. Someday we won´t lose the people we love.
But when is someday? Someday is today.
This is an extraordinary moment. One we have been working toward since 1949,
when The Leukemia & Lymphoma Society was founded.
In our 60+ years LLS has invested nearly a billion dollars to accelerate cancer
tratments once thought impossible.
In 1964, for example, the five-year survival rate for the most common chilhood
leukemia was 3%. Today it´s 90%.
Today, thanks to LLS, hundreds of thousands diagnosed with blood cancer
are living a normal life, free of chemo or radiation, may managing their
condition with just a daily pill.
Blood cancer research has long been the gateway to new therapies for many
cancer patients. Almost half the new cancer therapies approved by the FDA
between 2000 and 2012 were first approved for blood cancer patients, many
with research supported by LLS.
Simply put, today we are closer than ever to cures for many kinds of blood
cancers. We are at the brink of life-saving breakthroughs. We can see the
end of cancer from here.
With your donations, you can help make the end come sooner.
Give at lls.org or call 888-HELP-LLS